Objective: TORS is a minimally invasive surgical alternative to chemoradiotherapy for oropharyngeal malignancies. While early postoperative oropharyngeal dysphagia is linked to TORS, this study explores both subjective and objective swallowing outcomes.
Study Design: Retrospective and prospective review of the patients who underwent TORS for oropharyngeal malignancy from 2018 to 2023.